The rewarding property of opioids likely contributes to their abuse potential. Therefore, determining the genetic basis of opioid reward could aid in understanding the neurobiological mechanisms of opioid addiction, provided that it is a heritable trait. Here, we characterized the rewarding property of the widely abused prescription opioid oxycodone (OXY) in the conditioned place preference (CPP) assay using LG/J and SM/J parental inbred mouse strains and 17 parent-offspring families of a LG/J x SM/J F47/F48 advanced intercross line (AIL). Following OXY training (5 mg/kg, i.p.), SM/J mice and AIL mice, but not LG/J mice, showed an increase in preference for the OXY-paired side, suggesting a genetic basis for OXY-CPP. SM/J mice showed greater locomotor activity than LG/J mice in response to both saline and OXY. LG/J, SM/J, and AIL mice all exhibited robust OXY-induced locomotor sensitization. Narrow-sense heritability (h2) estimates of the phenotypes using linear regression and maximum likelihood estimation showed good agreement (r = 0.91). OXY-CPP was clearly not a heritable trait whereas drug free-and OXY-induced locomotor activity and sensitization were significantly and sometimes highly heritable (h2 = 0.30-0.84). Interestingly, the number of transitions between the saline-and OXY-paired sides emerged as a reliably heritable trait following OXY training (h2 = 0.46-0.66) and could represent a genetic component of drug seeking behavior. Thus, although OXY-CPP does not appear to be amenable to genome-wide quantitative trait locus (QTL) mapping, this protocol will be useful for mapping other traits potentially relevant to opioid abuse. 
INTRODUCTION
Prescription opioid drug abuse, in particular the non-prescription misuse of Oxycontin® (a sustained release formula of oxycodone; OXY) is a major socioeconomic problem in the United
States. There was a nine-fold increase in the amount of OXY prescribed in the U.S. between 1997 and 2007 (Manchikanti, et al 2010 , which drastically increased the potential for its diversion to non-medical use. The surge in OXY prescriptions coincided with a six-fold increase in the number of opioid-related emergency room visits, with OXY making the largest contribution in recent years (Manchikanti, et al 2010) . The epidemic in non-prescription opioid abuse highlights the timely and warranted need for determining the underlying factors that contribute to it.
Opioid addiction is a heritable complex trait (Goldman, et al 2005; Ho, et al 2010) , i.e., a proportion of the phenotypic variance can be explained by genetic factors. The primary molecular site of action for the motivational and analgesic properties of opioids is the Gi/Go coupled mu opioid receptor (Matthes, et al 1996) and genetic variants of OPRM1 have been associated with opioid addiction (Levran, et al 2012) . While many candidate gene association studies of opioid addiction have been reported for other genes (Ho, et al 2010) , unbiased, comprehensive genome-wide association studies are lacking.
Addiction can be defined by a repertoire of behaviors, each of which could vary in its presence and degree among individuals and across time. The individual phenotypes are presumably mediated by different (although not necessarily independent) sets of alleles, making the identification of genetic and biological factors more difficult. One way to reduce this complexity is to focus on individual phenotypes that are clearly heritable and associated with opioid abuse. An attractive, intuitive phenotype that may play a role in the early stage of the addiction process is the subjective degree to which a person likes a drug (drug liking), which can predict later patterns of opioid abuse (Haertzen, et al 1983) and is frequently used to evaluate the abuse potential of opioids, including different OXY formulations (Setnik, et al 2011; Webster, et al 2012) . There is substantial variation among individuals with regard to the motivational properties of opioids. In a recent human study examining the effects of the mu opioid receptor agonist alfentanil, many of the participants reported an initial positive experience followed by a negative one whereas others reported a predominantly positive experience, a neutral experience, or a predominantly negative one (Angst, et al 2012) . Whether this variation can in part be explained by genetic variation is not known; however the authors reported that opioid liking was not a heritable trait.
In both rodents and humans, the motivational properties of opioids can be assessed using a Pavlovian conditioning procedure known as the conditioned place preference ( (Bryant, et al 2012a) . AIL mice have a much greater number of historical recombination events than a typically used F 2 cross which can yield higher resolution quantitative trait loci (QTL) for complex traits (Cheng, et al 2010; Darvasi and Soller 1995) . AIL mice demonstrated a significant MA-CPP but in contrast to some of the locomotor phenotypes, MA-CPP was not a heritable trait (Bryant, et al 2012a) .
In the present study, we wished to estimate the heritability of OXY-CPP and the concomitant phenotypes of the CPP assay. We first examined OXY-CPP in the LG/J and SM/J The addition of seven extra families compared to our previous study (Bryant, et al 2012a) was included to increase our power to detect heritability. Next, we generated a correlation matrix of the behavioral phenotypes and assessed the relationship of OXY-CPP with these behaviors. We estimated the narrow-sense heritability of OXY-CPP and the concomitant phenotypes to assess the suitability of this population for conducting a genomewide QTL mapping study. Such efforts have been applied successfully toward other phenotypes associated with opioid addiction in mice, including liquid oral opioid consumption (Berrettini, et al 1994; Doyle, et al 2008; Ferraro, et al 2005) and opioid withdrawal (Kest, et al 2004; Kest, et al 2009) .
MATERIALS AND METHODS

Mice.
All experiments were performed in accordance with the National Institutes of Health
Guidelines for the Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at the University of Chicago. A 12h/12h light/dark cycle (lights on at 0600 h) was used in the mouse colony room. Behavioral testing was conducted between the hours of 1200 to 1700 h. Mice were same-sex housed in standard shoebox cages with corncob bedding in groups of two to five per cage.
30
LG/J mice (15 females, 15 males) and 30 SM/J mice (15 females, 15 males) were purchased from The Jackson Laboratory (Bar Harbor, ME) at 6 weeks of age and tested at 9-11 weeks of age. ) and two injections of SAL separated by 48 h (D3, D5) and were confined to the appropriate side for each training session. Mice were then returned to their home cages and left undisturbed on D6-D7. On D8, final preference for the OXY-paired side was assessed by administering a SAL injection (10 ml/kg, i.p.) to the mice, placing them on the SAL-paired side facing the entryway to the OXY-paired side, and providing free access to both sides. OXY-CPP is presented as the time spent on the OXY-paired side on D1 (D1 CPP) versus D8 (D8 CPP) and as the difference in time spent on the OXY-paired side between D1 and D8 (D8-D1 CPP).
The main reason we chose to report both CPP measures was to provide as much information as possible in interpreting the findings with the parental strains and the correlation among the variables in AIL mice. Because our main focus was CPP, we wanted to fully dissect the phenotype and to provide heritability estimates for all components of CPP.
Behavioral analysis. After establishing that sex did not interact with strain for each behavior, we combined sexes for analyses using repeated measures ANOVA (day was the repeated measure), unpaired t-tests to determine the source of strain effects, and paired t-test to determine the source of effects caused by day. The significance level was set to 0.05 and was
Bonferroni-corrected in reporting significant post-hoc results. Pearson's correlation coefficients (r) were reported for the correlation matrix of the behavioral phenotypes with the significance level set to 0.05 (Bonferonni-corrected for the 66 pairwise tests (p < 0.0008).
Heritability estimates. We estimated the narrow-sense heritability (h 2 ), or the proportion of phenotypic variance explained by additive genetic variance, using two methods. First, we used midparent-offspring linear regression of the F 47 and F 48 generations of AIL mice whereby h 2 equaled the slope of the regression line of the offspring averages of the 17 families regressed and non-genetic components, and estimate the heritability using the maximum likelihood estimation of the variance components (Abney, et al 2000) . The S.E. for maximum likelihood analysis was calculated using the the jackknife (delete-1) resampling method (Shao and Tu 1995).
RESULTS
OXY-CPP in
LG/J and SM/J mice. The 8-day OXY-CPP protocol is illustrated in Figure 1 and is essentially a shorter version of our previously published protocol (Bryant, et al 2012a) . In examining LG/J and SM/J strain differences in OXY-CPP, repeated measures ANOVA (D1, D8)
indicated an effect of day (F 1,58 = 3.96; p = 0.05) but no significant effect of strain (F 1,58 = 1.76; p = 0.19). SM/J showed an initially lower preference for the OXY-paired side on D1 compared to
LG/J (t 58 = 2.47; p = 0.017; "#"; Figure 2A ) and a significant increase in time spent on the OXYpaired side on D8 (t 29 = 3.79; p = 0.0007; "*"; Figure 2A ). In contrast, LG/J mice showed no significant change in preference for the OXY-paired side (t 29 < 1). In examining OXY-CPP as measured by D8-D1 over the 30 min session (D8-D1 CPP), there was no significant strain difference (t 58 = 1.06; p = 0.29; Figure 2B ). However, when considering the first 5 min of D8-D1 CPP assessment, SM/J mice clearly showed a significantly greater OXY-CPP than LG/J mice as measured by D8-D1 (t 58 = 3.48; p < 0.0001 data not shown).
In examining strain differences in locomotor activity during preference assessment on D1 and D8, repeated measures ANOVA indicated a significant strain x day interaction (F 1,58 = 20.54; p < 0.0001).
LG/J mice showed a significant decrease in activity from D1 to D8 (t 29 = F o r R e v i e w O n l y 9 8.15; p<0.0001; "*"; Figure 2C ) which contributed to the strain difference on D8 whereby SM/J mice showed significantly greater locomotor activity than LG/J mice (t 58 = 3.04; p = 0.0036; "#"; Figure 2C ).
OXY-CPP in AIL mice. Similar to SM/J mice, AIL mice showed a comparable increase in time spent on the OXY-paired side on D8 (t 208 = 8.95; p < 0.0001; "*"; Figure 2D , E), indicating OXY-CPP. There was a small but significant decrease in locomotor activity during preference assessment from D1 to D8 (t 208 = 3.61; p < 0.0001; "*"; Figure 2F ).
Locomotor activity during OXY and SAL training days in LG/J and SM/J mice. In examining locomotor activity across days in LG/J and SM/J mice, there was a main effect of strain (F 1,58 = 13.97; p = 0.0004) day (F 3,174 = 185.18; p < 0.0001), and a strain x day interaction (F 3,174 = 8.86; p < 0.0001). The strain x day interaction was in part explained by SM/J mice showing significantly greater locomotor activity than LG/J mice on D2, D3, and D4 (t 58 = 3.41, 4.18; 3.35; p < 0.0013; "#"; Figure 3A ), but not on D5 (t 58 < 1). The effect of day was in part explained by both LG/J and SM/J showing a robust locomotor stimulant response to OXY on D2 relative to SAL treatment on D3 (t 29 = 13.56, 8.23; p < 0.0001; Figure 3A ) and on D4 relative to D5 (t 29 = 12.96, 10.71; p < 0.0001; Figure 3A ). Furthermore, both LG/J and SM/J mice showed a significantly greater locomotor response to the second OXY injection on D4 relative to D2 (t 29 = 5.03, 4.78; p < 0.0001; "*"; Figure 3A ), indicating locomotor sensitization. In examining strain differences in the degree of locomotor sensitization as measured via the D4-D2 subtraction measure, there was no significant difference (t 58 < 1; Figure 3B ).
Locomotor activity during OXY and SAL training days in AIL mice. In examining locomotor activity across days, AIL mice showed a robust locomotor stimulant response to OXY on D2 relative to SAL treatment on D3 (t 208 = 12.91; p < 0.0001; Figure 3C ) and on D4 relative to D5
(t 208 =18.82; p < 0.0001; Figure 3C ). Furthermore, AIL mice showed a significantly greater locomotor response to the second OXY injection on D4 relative to D2 (t 208 = 18.82; p < 0.0001; Figure 3C ), indicating locomotor sensitization. The degree of locomotor sensitization in AIL mice as measured via the D4-D2 subtraction measure is presented in Figure 3D .
Correlation matrix of OXY-CPP and concomitant phenotypes. A correlation matrix of OXY-
CPP and the concomitant phenotypes is shown in Table 1 . Notably, there was a small but significant positive correlation between D1 CPP and D8 CPP (r = 0.26), indicating that a lower initial preference for the OXY-paired side in part predicted a lower final preference for the OXYpaired side. However, when considering the negative correlation between D1 CPP and D8-D1 CPP (r = -0.51), it was evident that a lower initial preference likely permitted a larger increase in preference. D8 CPP also showed a positive correlation with D8-D1 CPP (r=0.7), indicating that the D8-D1 measure can largely be explained by the final preference for the OXY-paired side on D8 (Table 1) .
Initial locomotor activity in the freely accessible CPP apparatus on D1 (D1 ACT)
predicted only the degree of activity exhibited following SAL treatment (and not OXY treatment)
which was expressed either in the confined chamber on D3 and D5 (D3 ACT, D5 ACT; r = 0.47, 0.45) or following final preference assessment on D8 (D8 ACT; r = 0.62). D1 ACT also correlated with the transitions between the SAL-and OXY-paired sides on D1 (r = 0.57) and to a lesser extent, on D8 (r = 0.37; Table 1 ).
Locomotor activity between OXY training days (D2 ACT, D4 ACT) and between SAL training days (D3 ACT, D5 ACT) were highly correlated within the same treatment (r = 0.81, 0.8 respectively) but not across treatments (r = 0.16-0.22; p > 0.0008; We observed a significant degree of OXY-induced locomotor sensitization in AIL mice as evidenced by the increase in activity from D2 to D4 ( Figure 3C, D) . Therefore, we wanted to determine the relationship of locomotor sensitization as measured by the difference in locomotor activity between D2 and D4 (D4-D2 ACT) with the other phenotypes. Importantly, the only variable that correlated with D4-D2 ACT was D4 ACT (r = 0.61) and not D2 ACT (r = 0.02) or drug-free locomotor activity (r = -0.03-0.08; Table 1 ), indicating that OXY-induced locomotor sensitization is a phenotype that is distinct from acute OXY sensitivity.
One final variable we were interested in was the number of transitions between the SALand OXY-paired sides (side changes; "SD CH") as this could represent a component of drug seeking behavior (see Discussion). This behavior on D1 (SD CH D1) and D8 (SD CH D8) correlated with D1 ACT and D8 ACT (r=0.37-0.67; p > 0.0008; Table 1 ), reflecting that transitioning between sides necessitates an increase in activity. The most interesting observation regarding this behavior was that only SD CH D8 correlated with OXY-induced locomotor activity on D2 and D4 (r = 0.29, 0.23; p < 0.0008) and not SD CH D1 (r = 0.11, 0.13; p > 0.0008; Table 1 ), indicating that this behavior is predicted by the acute and sensitized drug response and could represent a component of conditioned drug seeking behavior. Table 2 lists the heritability estimates obtained from regression analysis and maximum likelihood estimation.
Heritability of OXY-CPP and conconmitant phenotypes in AIL mice.
There was good agreement among the variables between the two methods of estimation (r = 0.91). OXY-CPP as measured both via the time spent on the OXY-paired side on D8 (D8 CPP) and via the difference in time spent on the OXY-paired side between training and test (D8-D1 CPP) was not significantly heritable (h2 = -0.11-0.14; Table 2 ). Because we observed a clear peak in D8-D1 CPP during the first 5 min of assessment in SM/J and AIL mice (data not shown),
we also examined heritability for this time point but it was not significant either (data not shown).
In contrast, most measures of drug free-and OXY-induced locomotor activity were significantly Table 2 ). Specifically, locomotor activity during SAL training days (D3, D5) exhibited the highest degree of heritability among the phenotypes (h 2 = 0.50-0.83) whereas OXY-induced locomotor activity (D2 ACT, D4 ACT) and activity during preference assessment days (D1, D8) exhibited lower, but still reliable h 2 estimates that ranged from 0.30 to 0.59 (Table 2) . Interestingly, the number of transitions between the OXY-and SAL-paired sides was not consistently heritable before OXY training (SD CH D1; h 2 = 0.18-0.4) but emerged as a highly heritable trait following OXY training on D8 (SD CH D8; h 2 = 0.46-66; Table 2 ).
DISCUSSION
We established a significant OXY-CPP in SM/J and AIL mice, but not in LG/J mice ( OXY-CPP was not a heritable trait as measured via D8 CPP or D8-D1 CPP (Table 2 ). This observation strongly suggests that genetic variation does not contribute to the conditioned rewarding properties of opioids, at least under these conditions in AIL mice. It is possible that additional training sessions may induce a more robust OXY-CPP that is heritable. However, in our previous study, we did not find any change in MA-CPP or improvement in heritability estimates following an additional week of CPP training in AIL mice (Bryant et al., 2012) .
The lack of heritability of opioid reward in mice supports a recent twin study in humans where the subjective liking of the highly selective mu opioid receptor agonist alfentanil was not heritable (h 2 = 0-0.05) and contrasted with other traits that were heritable such as opioid disliking (h 2 = 0.36) and opioid nausea (h 2 = 0.56-0.59) (Angst, et al 2012) . However, it is In agreement with our previous findings in AIL mice (Bryant, et al 2012a) , locomotor activity in response to a SAL injection (D1 ACT, D8 ACT, D3 ACT, D5 ACT; Figure 2F ; Figure   3C ) was moderately to highly heritable (h 2 = 0.35-0.66; Table 2 ), demonstrating the reliability of our estimates. This is important because both studies were potentially underpowered to detect significant heritability with only 10-17 parent-offspring observations (Klein, et al 1973; Klein 1974) . Here, we utilized 17 observations which decreased the S.E. of the phenotypes listed above from a range of 0.19-0.33 (Bryant, et al 2012a) to a range of 0.08-0.2 (Table 2 ).
Sensitivity to OXY-induced locomotor activity on D2 and D4 in AIL mice ( Figure 3C ) was reliably heritable (h2 = 0.30-0.59; Table 2 ) and supports previous estimates obtained for morphine-induced locomotor stimulation in an inbred strain panel (Belknap, et al 1998) and cocaine-induced locomotor activity in a recombinant inbred strain panel (Philip, et al 2010) . We previously identified QTLs on chromosome 11 and 15 that influenced opioid -induced locomotor activity (Bryant, et al 2009; Bryant, et al 2012b) , further supporting a genetic contribution to this trait. Additionally, LG/J, SM/J, and AIL mice exhibited a robust locomotor sensitization response to 5 mg/kg OXY, showing a large increase in distance traveled from D2 to D4 (Figure 3 ). This phenotype was also heritable in AIL mice as estimated via maximum likelihood (h 2 = 0.51) but Table 2 ). QTLs for locomotor sensitization to cocaine and ethanol have been identified (Cunningham 1995; Philip, et al 2010; Phillips, et al 1995; Phillips, et al 1998; Tolliver, et al 1994; Vendruscolo, et al 2009) ; thus, we believe that QTLs for oxycodone-induced locomotor sensitization will also be identified. Inbred strain differences in sensitization to heroin-induced locomotor stimulation (Szumlinski, et al 2005) Table 1 ), this indicates that phenotypic variation in OXY-induced locomotor sensitization is caused by alleles that regulate neuroplasticity as a consequence of OXY exposure and not by alleles that induce pre-existing neurobiological differences to affect, e.g., acute OXY sensitivity. Thus, OXY sensitization could be a specific and genetically tractable behavioral proxy of the neurobiological adaptations accompanying the early addictive process and could be combined with heritable intermediate phenotypes relevant to sensitization (e.g., striatal dopamine release).
An interesting finding of this study was that the number of transitions between the OXYand SAL-paired sides emerged as a reliably heritable trait following OXY training (SD CH D8; h2 = 0.46-0.66; Table 2 ) and correlated with OXY-induced locomotor activity on D2 and D4 (r = 0.29, 0.23; Table 1 ). That the acute and sensitized drug response predicted this behavior unveiled a Pavlovian-conditioned property of this trait because it showed that the intensity of the unconditioned stimulus predicted the degree of conditioned response. A previous study (2007) employed a three-chamber design in rats which provided a neutral chamber and allowed the rats to choose the morphine-paired side relevant to a neutral condition rather than, e.g., choose the morphine-paired side to avoid the non-morphine side (which could be associated with drug withdrawal). Employing a three-chamber design would permit the isolation of approach behavior toward OXY-paired stimuli and this could be a heritable trait associated with OXY-CPP. It would also allow us to distinguish between whether strains or individual mice specifically avoid entering one particular side or if they exhibit a general avoidance of both the OXY-and SAL-paired sides. This could affect the strain differences and individual differences in OXY-CPP as well as the relationship among the concomitant variables.
A perplexing result we observed in this study was that LG/J mice showed a significantly higher initial preference for the drug-paired side compared to the MA study (p = 0.0007) which could contribute to the lack of OXY-CPP in this strain. The source of this strain x experiment interaction is not clear but could be explained by any number of factors. First, in the previous study, mice were tested in the morning through the afternoon hours (0800 h -01700 h) whereas in the present study, mice were only tested in the afternoon hours. The detection of mouse strain differences in behavioral phenotypes has been shown to be circadian-dependent (Hossain, et al 2004) . Second, different experimenters tested the parental strains: In the previous study, C.D.B. phenotyped the LG/J and SM/J strains whereas in the present study, L.A.K. phenotyped these strains. A previous study demonstrated the importance of experimenter on behavioral phenotypes (Chesler et al., 2002) which could potentially interact with genotype. Importantly, despite the discrepancy in the parental strain data, the D1 CPP Our findings add to the growing number of studies demonstrating that CPP is not a heritable trait and thus may not be amenable to forward genetic analysis. We have shown that several other phenotypes were heritable, including sensitivity the acute locomotor stimulant response, locomotor sensitization, and transitions between the SAL-and OXY-paired sides which may represent a heritable component of drug seeking behavior. Because of the high resolution afforded by QTL mapping in AIL mice, the use of this protocol could rapidly lead to the identification of alleles important for the initial behavioral and neural plasticity that may be important for the transition to opioid addiction. Last, because heritability estimates can depend on the population that is ascertained (Visscher, et al 2008) , employing additional mapping populations with a greater degree of genetic diversity (Svenson, et al 2012) Figure 1 : OXY-CPP protocol. We used an 8-day protocol whereby mice were assessed for initial preference for the OXY-paired side on day 1 (D1, initial preference; Initial pref.), trained over four days with alternating injections of OXY (D2, D4) and SAL (D3, D5) in the respective contexts, and assessed for OXY-CPP on D8. Each day represents a 30 min session. Day = day of the protocol; Tx = treatment for that day; SAL = saline treatment; OXY = oxycodone treatment; -= mice were left undisturbed in their home cage in the vivarium on these days. 190x254mm (300 x 300 DPI) 
